Clinical Trial Update: Study of the Disease Process of Lymphangioleiomyomatosis

View source ↗

Summary

NHLBI-sponsored clinical trial update focusing on the disease process of lymphangioleiomyomatosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Pneumothorax
• Tuberous Sclerosis Complex

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Disease, Pneumothorax | Status: RECRUITING